POST-GENOMIC ERA of epigenetics will mean that purely sequence data for some disease genes may not be enough. Assessment of whether a gene is active or not (by methylation analysis etc) is an important emerging consideration. New sample prep methods may be needed to assess both sequences and epigenetic changes. See this great slide show. ”
”
http://lnkd.in/rUwHBY
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022